background_placeholder
Journal of Clinical Oncology

Articles about Journal of Clinical Oncology

     
Kies meer

Trending
Er zijn @count nieuwe artikelen
Thursday, December 8, 2022 - 01:32Nieuw
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor
Wednesday, December 7, 2022 - 01:32 - In Wetenschap
Rucaparib Maintenance in Upfront Ovarian Cancer: The Long-Lasting Challenge of Predicting Response to Poly (ADP-ribose) Polymerase Inhibitors
Tuesday, December 6, 2022 - 09:24 - In Wetenschap
Symptom Clusters in Childhood Cancer Survivors
Tuesday, December 6, 2022 - 09:24 - In Wetenschap
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
Tuesday, December 6, 2022 - 01:32 - In Wetenschap
Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study
Monday, December 5, 2022 - 19:40 - In Wetenschap
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
Monday, December 5, 2022 - 19:40 - In Wetenschap
Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
Monday, December 5, 2022 - 19:40 - In Wetenschap
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Saturday, December 3, 2022 - 09:40 - In Wetenschap
Redefining Gleason 6 Prostate Cancer Nomenclature: The Surgeon's Perspective
Saturday, December 3, 2022 - 09:40 - In Wetenschap
Resistance Mechanisms to Anti–Epidermal Growth Factor Receptor Therapy in RAS/RAF Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy

Kies uw tags